Premji Invest focuses on evergreen capital, aiming to refine robotic intelligence and AI-driven drug discovery platforms. The company is dedicated to developing biopharmaceutical gene therapies with a purpose-driven approach. With over 165 total investments and $15 billion in evergreen capital, Premji Invest is committed to for-profit investing for the greater good, supporting long-term growth and innovation.
We're tracking Premji Invest's market expansion
How Premji Invest's international expansion compares to its competitors
Premji InvestYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Premji InvestYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
Redefining Protection for a Nation: The SBI General Insurance Story
ActiveReliance Retail, CP Group, Swiggy, and PremjiInvest are competing to acquire Metro AG's Indian cash-and-carry operations. The deal is valued at $1-1.5 billion. Non-binding offers are due this week, with firm offers expected in two months.
ADIA subsidiary leads $120m Series E funding in Purplle, valuing it at $1.3bn. Investment includes primary and secondary shares, with new investors joining.
Indian family offices are diversifying investments by backing startups across sectors, with notable participants like Premji Invest and MEMG in major funding rounds.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Premji Invest's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
